News On Japan

Japan Advances iPS Cell Technology with New Osaka Facility

OSAKA, Mar 20 (News On Japan) - A new facility for the research and production of induced pluripotent stem (iPS) cells has been completed in Osaka's Nakanoshima district and was unveiled to the press on March 19th.

Named "Yanai My iPS," the facility was established with a donation from Tadashi Yanai, CEO of Fast Retailing, the company behind Uniqlo and GU. iPS cells, which can transform into various types of cells, are seen as key to regenerative medicine. Currently, they are primarily derived from donor cells, which carries the risk of immune rejection. However, using a patient’s own cells could significantly reduce this risk.

The facility is focusing on developing technology for autologous iPS cells, which are created from a patient’s own tissues. Traditionally, producing iPS cells required manual labor, pushing costs into the tens of millions of yen. However, the new facility aims to provide autologous iPS cells to research institutions for about 1 million yen by the end of this year. The ultimate goal is to begin clinical trials for human treatment by 2028.

iPS cells are reprogrammed from adult cells, such as skin or blood cells, into a pluripotent state, allowing them to transform into almost any cell type. This breakthrough has opened new possibilities for regenerative medicine, offering potential treatments for diseases such as Parkinson’s and macular degeneration while avoiding the ethical concerns associated with embryonic stem cells.

Japan’s government has invested heavily in iPS cell research through institutions like the Center for iPS Cell Research and Application (CiRA) at Kyoto University, led by Yamanaka. Public and private sectors have collaborated to accelerate clinical applications, with several groundbreaking trials already conducted. In 2014, Japan carried out the world’s first iPS cell transplant for macular degeneration. In 2020, iPS-derived cells were tested as a treatment for Parkinson’s disease, showing early promise. More recently, researchers have explored using iPS cells to generate lab-grown blood for transfusions and potential therapies for heart and liver conditions.

A major challenge in iPS research has been the high cost of production, with patient-specific iPS cells initially costing tens of millions of yen. Recent efforts aim to reduce costs and develop mass production systems, making iPS treatments more widely accessible. New facilities, such as the recently opened Yanai My iPS center in Osaka, are working to lower production costs and pave the way for clinical use, with human trials expected in the coming years.

Source: Television OSAKA NEWS

News On Japan
POPULAR NEWS

The newly established Hokkaido Valley Vision Council aims to create a 'Hokkaido version of Silicon Valley' by promoting development around next-generation semiconductor firm Rapidus and transforming the region from Tomakomai to Ishikari into a hub for advanced technology.

At least 24 mountain climbing accidents have occurred in Nagano Prefecture since the start of the Golden Week holidays in late April, resulting in four fatalities.

Head lice, small parasitic insects that feed on blood from the scalp, are once again spreading among children in Japan as physical contact increases following the COVID-19 pandemic. In Sapporo, where outbreaks have been reported in schools, local officials are urging caution.

A wooden church in Kasamatsu, Gifu Prefecture collapsed on Saturday evening, after years of delayed demolition plans due to financial constraints.

Reporters Without Borders has released its 2025 World Press Freedom Index, ranking Japan 66th out of 180 countries and regions surveyed, just behind Timor-Leste (65th) and Fiji (64th).

MEDIA CHANNELS
         

MORE Sci-Tech NEWS

A groundbreaking project to develop the world’s first artificial satellite made of wood is underway in Kyoto, led by astronaut Takao Doi. The initiative is part of a broader push toward environmentally sustainable space exploration.

Sustainable aviation fuel (SAF), made from used cooking oil and other waste materials, has been produced domestically in Japan for the first time and supplied to an aircraft.

The Nuclear Regulation Authority approved a draft review on April 30th confirming that safety measures at Hokkaido Electric Power’s Tomari Nuclear Power Plant Unit 3 comply with the country’s updated safety standards. This effectively clears the unit for restart, making it the 18th reactor at 11 nuclear plants nationwide to pass the review under the new regulatory framework.

Vegetables that were destined for disposal are being given a new purpose as crayons that retain their natural colors and even a faint trace of their original scent.

One of the main attractions at the Osaka-Kansai Expo, the "flying car," experienced an unexpected malfunction, raising concerns about safety and delaying its return to operation.

What does it feel like to have Restless Legs Syndrome? From my own experience, it is like being buried in sand, with a deep, heavy ache that can only be relieved by moving the legs or through constant massage. Resisting the urge to move can trigger a sense of panic, similar to claustrophobia—just when all you want to do is sleep. It’s exhausting, often lasting through the night and into the early morning hours, sometimes even longer.

Organic fluorine compounds known as PFAS—suspected to be harmful to human health—have been detected at concentrations exceeding the national provisional target in rivers and groundwater at 242 sites across 22 prefectures, according to a government survey.

Kyoto University and its research team have revealed that several former employees of Daikin Industries developed lung diseases, potentially linked to exposure to PFAS (per- and polyfluoroalkyl substances), a group of chemical compounds used in industrial manufacturing.